Search

Your search keyword '"Takeshi Hisamatsu"' showing total 34 results

Search Constraints

Start Over You searched for: Author "Takeshi Hisamatsu" Remove constraint Author: "Takeshi Hisamatsu" Search Limiters Full Text Remove constraint Search Limiters: Full Text
34 results on '"Takeshi Hisamatsu"'

Search Results

1. Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers

2. Figure S1, S2, S3, S4 and S5 from PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer

3. Data from Therapeutic Silencing of KRAS Using Systemically Delivered siRNAs

4. Supplementary Table 1 and 2 from Potential Role of mTORC2 as a Therapeutic Target in Clear Cell Carcinoma of the Ovary

5. Supplementary Figures 1 - 2 from Therapeutic Silencing of KRAS Using Systemically Delivered siRNAs

7. Table S1, Table S2, Table S3, Table S5 from PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer

8. Data from Potential Role of mTORC2 as a Therapeutic Target in Clear Cell Carcinoma of the Ovary

9. Table S6 from PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer

10. Data from PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer

11. Data from Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer

12. An integrated supplementary document for 3 figures from Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer

13. Data from The Activity of Trabectedin As a Single Agent or in Combination with Everolimus for Clear Cell Carcinoma of the Ovary

14. Supplementary Figure S1 from The Activity of Trabectedin As a Single Agent or in Combination with Everolimus for Clear Cell Carcinoma of the Ovary

15. Supplementary figures S1-5, Tables S1-5 from XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A

16. Proangiogenic effects of MSMP in ovarian cancer

17. Role of ADP receptors on platelets in the growth of ovarian cancer

18. A Case of Inguinal Hernia of a Rudimentary Uterus Associated with Mayer-Rokitansky-Küster-Hauser Syndrome Successfully Diagnosed and Treated with Laparoscopic Surgery

19. PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer

20. Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma

21. Preclinical Efficacy for AKT Targeting in Clear Cell Carcinoma of the Ovary

22. Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers

23. The Activity of Trabectedin As a Single Agent or in Combination with Everolimus for Clear Cell Carcinoma of the Ovary

24. XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A

25. Abstract 473: PRKRA/PACT expression promotes chemoresistance in mucinous ovarian cancer

26. Abstract 4144: Role of CTGF in hyperthermia resistance in ovarian and uterine cancers

27. Therapeutic Silencing of KRAS using Systemically Delivered siRNAs

28. Uterine cervical cancer displaying tumor-related leukocytosis: a distinct clinical entity with radioresistant feature

29. Potential Role of mTORC2 as a Therapeutic Target in Clear Cell Carcinoma of the Ovary

30. miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression

31. Abstract 378: The significance of vascular endothelial growth factor C in the lymphangiogenesis and lymph node metastasis of ovarian cancer

32. Abstract 2228: mTORC2 is a promising therapeutic target in epithelial ovarian cancer

33. Aging and sense of direction

34. Uterine Cervical Cancer Displaying Tumor-Related Leukocytosis: A Distinct Clinical Entity With Radioresistant Feature.

Catalog

Books, media, physical & digital resources